Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction
NCT02672566
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
82
Enrollment
OTHER
Sponsor class
Conditions
Fetal Growth Retardation
Interventions
DRUG:
Enoxaparin
OTHER:
Usual care
Sponsor
Centre Hospitalier Universitaire de Saint Etienne